MacroGenics Statistics
Total Valuation
MacroGenics has a market cap or net worth of $94.81 million. The enterprise value is -$14.58 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MacroGenics has 63.21 million shares outstanding. The number of shares has increased by 0.95% in one year.
| Current Share Class | 63.21M |
| Shares Outstanding | 63.21M |
| Shares Change (YoY) | +0.95% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | 61.19% |
| Float | 52.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| Forward PS | 1.88 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.55.
| Current Ratio | 5.22 |
| Quick Ratio | 4.85 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.97 |
Financial Efficiency
Return on equity (ROE) is -81.13% and return on invested capital (ROIC) is -54.99%.
| Return on Equity (ROE) | -81.13% |
| Return on Assets (ROA) | -26.53% |
| Return on Invested Capital (ROIC) | -54.99% |
| Return on Capital Employed (ROCE) | -50.19% |
| Revenue Per Employee | $374,270 |
| Profits Per Employee | -$222,540 |
| Employee Count | 341 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 30.59 |
Taxes
In the past 12 months, MacroGenics has paid $1.05 million in taxes.
| Income Tax | 1.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.21% in the last 52 weeks. The beta is 1.51, so MacroGenics's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -60.21% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 1.72 |
| Relative Strength Index (RSI) | 44.86 |
| Average Volume (20 Days) | 1,035,260 |
Short Selling Information
The latest short interest is 3.56 million, so 5.64% of the outstanding shares have been sold short.
| Short Interest | 3.56M |
| Short Previous Month | 3.56M |
| Short % of Shares Out | 5.64% |
| Short % of Float | 6.78% |
| Short Ratio (days to cover) | 4.57 |
Income Statement
In the last 12 months, MacroGenics had revenue of $127.63 million and -$75.89 million in losses. Loss per share was -$1.21.
| Revenue | 127.63M |
| Gross Profit | -55.85M |
| Operating Income | -113.58M |
| Pretax Income | -74.84M |
| Net Income | -75.89M |
| EBITDA | -106.06M |
| EBIT | -113.58M |
| Loss Per Share | -$1.21 |
Full Income StatementBalance Sheet
The company has $146.40 million in cash and $37.01 million in debt, giving a net cash position of $109.39 million or $1.73 per share.
| Cash & Cash Equivalents | 146.40M |
| Total Debt | 37.01M |
| Net Cash | 109.39M |
| Net Cash Per Share | $1.73 |
| Equity (Book Value) | 67.00M |
| Book Value Per Share | 1.06 |
| Working Capital | 187.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$162.47 million and capital expenditures -$2.29 million, giving a free cash flow of -$164.76 million.
| Operating Cash Flow | -162.47M |
| Capital Expenditures | -2.29M |
| Free Cash Flow | -164.76M |
| FCF Per Share | -$2.61 |
Full Cash Flow StatementMargins
Gross margin is -43.76%, with operating and profit margins of -89.00% and -59.46%.
| Gross Margin | -43.76% |
| Operating Margin | -89.00% |
| Pretax Margin | -58.64% |
| Profit Margin | -59.46% |
| EBITDA Margin | -83.10% |
| EBIT Margin | -89.00% |
| FCF Margin | n/a |
Dividends & Yields
MacroGenics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.95% |
| Shareholder Yield | -0.95% |
| Earnings Yield | -80.04% |
| FCF Yield | -173.78% |
Analyst Forecast
The average price target for MacroGenics is $3.20, which is 113.33% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.20 |
| Price Target Difference | 113.33% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -0.40% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
